Energy stocks suffer broad selloff, led by Halliburton, as crude oil falls to more than 5-week low
Energy stocks were suffering a broad beating Tuesday, as a selloff in crude prices was exacerbated by a big decline in the broader stock market. The Energy Select Sector SPDR exchange-traded fund (XLE) sank 4.4% toward a five-week low, with all 23 equity components losing ground. With the ETF (XLE), Chevron Corp.'s stock (CVX) slumped 4.5%, enough to pace the decliners within the Dow Jones Industrial Average , which dropped 420 points, or 1.2%. The biggest XLE decliner was Halliburton Co.'s stock (HAL), which dove 8.0%, while Occidental Petroleum Corp.'s stock (OXY) was the best performer, but still lost 2.2%. Among other more-active XLE components, shares of Exxon Mobil Corp. (XOM) were down 3.7%, of Kinder Morgan Inc. (KMI) declined 2.5% and of Marathon Oil Corp. (MRO) slid 5.9%. Meanwhile, crude oil futures took a 5.2%, toward the lowest settlement in more than five weeks.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-02-23 1456ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track